PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2044 (105th)

To suspend temporarily the duty on the production of anti-cancer drugs.

openUnited States· United States Congress· EN

Introduced

25 June 1997

Last action

2 July 1997 · Referred

Status

See H.R.2622.

Sponsors

Rep. Matsui, Robert T. [D-CA-3]

Subjects

Discovery layer

Source updated

7 February 2024

Summary

Amends the Harmonized Tariff Schedule of the United States to suspend, through December 31, 2000, the duty on (3S)-2,2-dimethyl-3- thiomorpholine carboxylic acid (anti-cancer drug).

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 25 June 1997

    Introduced

    Referred to the House Committee on Ways and Means.

    Source: IntroReferral

  2. 25 June 1997

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 25 June 1997

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 2 July 1997

    Committee

    See H.R.2622.

    Source: Committee

  5. 2 July 1997

    Referred

    Referred to the Subcommittee on Trade.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.